BIRMINGHAM – More than 10,000 Alabamians have now received potentially life-changing genetic information through the Alabama Genomic Health Initiative (AGHI), a statewide precision-medicine effort led jointly by the HudsonAlpha Institute for Biotechnology and the University of Alabama at Birmingham (UAB).
While the initiative relies on statewide clinical partnerships, HudsonAlpha’s research leadership and technological innovation have been central to reaching this milestone and expanding access to genomic medicine across all 67 counties.
A core feature of AGHI is returning personalized, clinically guided results to participants. Nearly 9,000 people have received information about hereditary cancer, cardiovascular risk and metabolic conditions. The testing panel has grown from 59 to 81 genes since 2017, and results are reviewed by genetics experts to help participants and their physicians make informed decisions about prevention and care.
Since 2017, AGHI has offered whole genome sequencing (WGS) to patients with unresolved medical conditions, providing answers for about 22% of undiagnosed cases. In 2024, HudsonAlpha introduced long-read genome sequencing (lrGS), boosting diagnostic yield by an additional 7% by uncovering complex variants standard methods often miss. These technologies have ended years-long diagnostic odysseys for many families and opened the door to more targeted treatment options.
AGHI’s reach also includes pharmacogenomic testing, enabling physicians to prescribe medications tailored to a patient’s genetic profile. More than 2,500 Alabamians have received PGx results that are integrated directly into electronic health records for real-time prescribing support.
Leaders say the program’s strength comes from the UAB–HudsonAlpha partnership, combining clinical capacity with biotechnology expertise. The result, they note, is a national model for bringing precision medicine to both rural and urban communities.
To learn more or enroll, email AGHI@uabmc.edu, visit www.aghi.org or call 1-855-462-6850.
Click here to read the full news release.
